Abstract
(miR-10b) expression. Furthermore, we show that miR-10b is a novel downstream 68 effector of BRaf V600E and that BRaf V600E plays a causal role in the induction of miR-10b primary antibodies (1:1000) and horseradish peroxidase secondary antibodies were 91 from Santa Cruz Biotechnology, and tubulin (1:1000) antibody was from Sigma.
93
Ectopic expression and depletion of miR-10b 94 Mammalian expression vectors, MDH1-PGK-GFP 2.0-miR-10b and pBABE-puro-95 miR-10b sponge, were purchased from Addgene (Plasmids were deposited by
96
Weinberg lab) (13). Melanoma cells were stably transduced with viral particles 97 expressing miR-10b or miR-10 sponge as described previously (14).
99

In vitro Matrigel invasion assay
100
The polycarbonate membrane (8µ pore size) of FluoroBlok cell culture inserts (BD
101
Biosciences) was coated with 60 uL of Matrigel (1:26 in serum-free medium) (BD Biosciences) 102 and incubated at 37C for 2-3 hours. 1x10 4 of SK-Mel 28 cells were plated on these inserts.
103
700mL of chemo-attractive medium (Dulbecco's Modified Eagle's medium, 1% P/S and 10% 104 FBS) was added to the lower chambers (24-well BD Falcon TC companion plate). After 24 hours 105 of incubation, the insert bottoms were dipped in 1X PBS and stained in Calcein AM reconstituted 106 in DMSO to 1mg/mL-1ml in 700 ml 1X PBS (BD Biosciences). Digital images were captured on 107 EVOS inverted microscope along with manual cell count and fluorescence reading (485-538nM). 
TCGA data analysis
129
The publicly available TCGA data were directly downloaded from the TCGA Data were lysed with 20 mM Tris, pH 7.4, 150mM NaCl, 2mM EDTA, and 1% Triton X-100. 
Statistical analysis
151
All experiments were performed in triplicates. All the statistical analyses were 152 performed using the two-tailed student's t-test (GraphPad Prism software). we found that miR-10b expression was significantly down-regulated upon BRaf V600E 175 knock down (Fig 2a) . A decrease in miR-10b expression was also observed in M249, 176 which are BRaf V600E positive melanoma cells when BRaf V600E activity was down-177 regulated by vemurafenib (PLX4032), a pharmacological inhibitor of BRaf V600E (Fig 2b) . expressing BRaf V600E as compared to empty vector control (Fig 2c) . The drawback of Indeed, we observed significant correlation of miR-10b and Twist1 expression only in 219 BRaf V600E mutated melanoma clinical samples (Fig 3a and Table 1 ). The observed 220 correlation is specific as no significant correlation was observed between another E-box 221 transcription factor c-myc and miR-10b (Fig 3b and Table 2 ). Further studies validating anchorage-independent growth as measured in soft agar (Fig 4a) . This effect was not 252 cell type specific as a similar effect was observed with other wild-type BRaf melanoma 253 cells SK-MEL197. Similarly, depletion of miR-10b in high-miR-10b-expressing BRaf V600E 254 melanoma cells, SK-MEL 28, decreased their invasiveness (Fig 4b) . BRaf V600E is an anchorage-independent growth and invasiveness due to the loss of BRaf V600E in SK-
261
MEL 28 cells (Fig 5) . 
305
RhoC is a well-studied metastasis gene in melanoma and it is possible that BRaf V600E 306 utilizes the same miR-10b-HoxD10-RhoC axis to drive cancer cells invasion. Likewise,
307
Tbx2 can also play an equally important role in mediating the different effects on 308 melanomagenesis resulting from BRaf mutation.
309
In 2010, an orally available inhibitor of BRaf V600E increased the median 310 progression-free survival of patients with malignant melanoma harboring this mutation, 311 to more than 7 months (23). However, patients develop resistance to this drug due to 
